Chugai Pharmaceutical Co logo

4519 - Chugai Pharmaceutical Co Share Price

¥12430 25.0  0.2%

Last Trade - 3:10am

Sector
Healthcare
Size
Large Cap
Market Cap £50.54bn
Enterprise Value £48.06bn
Revenue £5.11bn
Position in Universe 8th / 3869
Bullish
Bearish
Unlock 4519 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

4519 Revenue Unlock 4519 Revenue

Net Income

4519 Net Income Unlock 4519 Revenue

Normalised EPS

4519 Normalised EPS Unlock 4519 Revenue

PE Ratio Range

4519 PE Ratio Range Unlock 4519 Revenue

Dividend Yield Range

4519 Dividend Yield Range Unlock 4519 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
4519 EPS Forecasts Unlock 4519 Revenue
Profile Summary

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated March 8, 1943
Public Since March 3, 1956
No. of Shareholders: n/a
No. of Employees: 7,432
Sector Healthcare
Industry Pharmaceuticals
Index Nikkei 225 , Nikkei 300 ,
Exchange Tokyo Stock Exchange
Shares in Issue 547,523,535
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4519 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4519
Upcoming Events for 4519
Thursday 23rd April, 2020
Q1 2020 Chugai Pharmaceutical Co Ltd Earnings Call (Japanese)
Thursday 23rd April, 2020
Q1 2020 Chugai Pharmaceutical Co Ltd Earnings Call
Wednesday 22nd April, 2020 Estimate
Q1 2020 Chugai Pharmaceutical Co Ltd Earnings Release
Monday 29th June, 2020
Dividend For 4519.T - 75.0000 JPY
Wednesday 1st July, 2020
Chugai Pharmaceutical Co Ltd Split For 4519.T - Ratio 3-1
Monday 27th July, 2020
Q2 2020 Chugai Pharmaceutical Co Ltd Earnings Release
Similar to 4519
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.